Mashhadian et al., 2022 - Google Patents
An integrative method to increase the reliability of conventional double emulsion methodMashhadian et al., 2022
- Document ID
- 9026586032576845353
- Author
- Mashhadian A
- Afjoul H
- Shamloo A
- Publication year
- Publication venue
- Analytica Chimica Acta
External Links
Snippet
Polymeric microspheres which can load biomolecules, cells and active agents play an important role in tissue engineering and drug delivery systems. The conventional double emulsion method has been frequently used to fabricate polymeric microspheres. However …
- 238000004945 emulsification 0 title abstract description 28
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making micro-capsules or micro-balloons
- B01J13/02—Making micro-capsules or micro-balloons
- B01J13/04—Making micro-capsules or micro-balloons by physical processes, e.g. drying, spraying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING
- B01F13/00—Other mixers; Mixing plant, including combinations of mixers, e.g. of dissimilar mixers
- B01F13/0059—Micromixers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Microfluidic-assisted fabrication of carriers for controlled drug delivery | |
| Forigua et al. | Recent advances in the design of microfluidic technologies for the manufacture of drug releasing particles | |
| Zhang et al. | Microfluidic methods for fabrication and engineering of nanoparticle drug delivery systems | |
| Kashani et al. | Microfluidics for core–shell drug carrier particles–a review | |
| Fontana et al. | Microfluidics as a cutting-edge technique for drug delivery applications | |
| Ekanem et al. | Structured biodegradable polymeric microparticles for drug delivery produced using flow focusing glass microfluidic devices | |
| Luo et al. | Microfluidic devices in fabricating nano or micromaterials for biomedical applications | |
| Maged et al. | Merits and advances of microfluidics in the pharmaceutical field: Design technologies and future prospects | |
| Abbaspourrad et al. | Controlling release from pH-responsive microcapsules | |
| Chong et al. | Advances in fabricating double-emulsion droplets and their biomedical applications | |
| Gañán-Calvo et al. | Building functional materials for health care and pharmacy from microfluidic principles and flow focusing | |
| Riahi et al. | Microfluidics for advanced drug delivery systems | |
| Davoodi et al. | Coaxial electrohydrodynamic atomization: Microparticles for drug delivery applications | |
| Thakur et al. | Nanofluids-based delivery system, encapsulation of nanoparticles for stability to make stable nanofluids | |
| Procopio et al. | Recent fabrication methods to produce polymer-based drug delivery matrices (experimental and in silico approaches) | |
| Mashhadian et al. | An integrative method to increase the reliability of conventional double emulsion method | |
| Seo et al. | Microfluidic assembly of monodisperse, nanoparticle-incorporated perfluorocarbon microbubbles for medical imaging and therapy | |
| Gunduz et al. | Continuous generation of ethyl cellulose drug delivery nanocarriers from microbubbles | |
| ES2216907T3 (en) | PROCEDURE FOR THE PRODUCTION OF MICRO- AND NANO-PARTICULES MORPHOLOGICALLY UNIFORMS THROUGH A MICROMIXER. | |
| Sundararajan et al. | Engineering polymeric Janus particles for drug delivery using microfluidic solvent dissolution approach | |
| Sharratt et al. | Precision polymer particles by flash nanoprecipitation and microfluidic droplet extraction | |
| Sun et al. | Silver-coated colloidosomes as carriers for an anticancer drug | |
| Shen et al. | Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics | |
| Domenech et al. | High loading capacity nanoencapsulation and release of hydrophobic drug nanocrystals from microgel particles | |
| Zhang et al. | Synthesis of oil-laden poly (ethylene glycol) diacrylate hydrogel nanocapsules from double nanoemulsions |